Title	Publication Date	Language	Citations
Hepatology at the Civil Hospital of Guadalajara, Fray Antonio Alcalde (HCGFAA) in the last 25 years and its international scientific productivity	2024/02/01	English
Survival of patients with hepatocellular carcinoma treated with immunotherapy experience of a third level center.	2024/02/01	English
The role of cirrhosis etiology in the development of acute kidney injury and death	2024/02/01	English
BUN/creatinine ratio associated with mortality in patients with cirrhosis and acute kidney injury.	2024/02/01	English
IGFBP2: a possible molecular link between liver, heart, and bloodstream during metabolic dysfunction-associated steatotic liver disease	2024/02/01	English
Hepatitis C Virus NS5A and Core protein induce hepatic stellate cells activation promoting fibrosis-related gene regulation on hepatocytes.	2024/02/01	English
Noninvasive markers of hepatic fibrosis and their clinical application in coronary artery disease.	2024/02/01	English
In vitro analysis of apoptosis in hepatic stellate cells cultured under steatogenic conditions	2024/02/01	English
Methyl-group donor supplementation beneficial effects on metabolic, histological, and inflammatory parameters in a murine model of alcoholic steatohepatitis	2024/02/01	English
Factors associated with mortality in patients with cirrhosis.	2024/02/01	English
Efficacy and safety of intravenous L-ornithine L-aspartate in patients with grade III and IV hepatic encephalopathy	2024/02/01	English
Hepatitis secondary to consumption of piñalim	2024/02/01	English
Impact of cholemic nephrosis on renal failure in cirrhotic patients	2024/02/01	English
Evaluation of the MELNa AGIB Scale to Predict Mortality in Patients with Cirrhosis and Variceal Hemorrhage.	2024/02/01	English
Characteristics of patients with overlap syndrome of autoimmune liver diseases in a third level hospital.	2024/02/01	English
Comparison of non-invasive scores for the evaluation of liver fibrosis in subjects with metabolic dysfunction-associated fatty liver disease (MAFLD)	2024/02/01	English
Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023	2024/02/01	English
Hepatic Steatosis Index (HSI): A Valuable Biomarker in Subjects with Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)	2024/02/01	English
25-hydroxyvitamin D deficiency as a factor associated with the development of Hepatic Encephalopathy in the Mexican population.	2024/02/01	English
Sword of Damocles: a hard blow from hepatitis A.	2024/02/01	English
Chronic liver damage in hemodialysis users. The importance of molecular tests for detection of hidden infection by hepatotropic viruses in high-risk groups	2024/02/01	English
Hepatitis A at the Hospital de Especialidades Centro Medico Nacional La Raza. Preliminary report.	2024/02/01	English
Bouveret syndrome, a rare clinical presentation of abdominal pain in a patient with diabetic ketoacidosis: A case report.	2024/02/01	English
Secondary Attack Rate of Hepatitis C Virus (HCV)	2024/02/01	English
Association of IFNL3 gene rs4803217 with spontaneous clearance of Hepatitis C virus in patients from West Mexico	2024/02/01	English
Pirfenidone induces translocation of sirt1 to nucleus and deacetylation of histone 3 slows down the development of fibrosis and tumorigenicity in a experimental model of hepatocarcinoma.	2024/02/01	English
Incidence and Associated factors to development of hyponatremia in a cohort of ambulatory patients with compensated liver cirrhosis	2024/02/01	English
Segmental portal hypertension secondary to chronic pancreatitis	2024/02/01	English
Pirfenidone decreases insulin, glucagon, leptin, plasminogen activator inhibitor 1, preventing nonalcoholic steatohepatitis and myocarditis in an obesity moldel	2024/02/01	English
Epidemiology and demographic aspects in patients with acute on chronic liver failure in a third-level care hospital in Mexico.	2024/02/01	English